Shanghai, China · Founded 2021 · Privately Held (backing)
Researcher and developer of drugs intend to serve the pharmaceutical industry. Kangabio is based in Shanghai, China and was founded in 2021. It has raised $29.9 million.
Last price · $/share
—
Implied valuation
—
Total raised
$29.9M
Last round
—
Team — not yet on record
No current team members for Kangabio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kangabio with a free account
·Watch Kangabio: the Monday email on marks, rounds and moves
